[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE233570T1 - Verwendung des leukämie-inhibitor-faktor und endothelin antagonisten - Google Patents

Verwendung des leukämie-inhibitor-faktor und endothelin antagonisten

Info

Publication number
ATE233570T1
ATE233570T1 AT96913814T AT96913814T ATE233570T1 AT E233570 T1 ATE233570 T1 AT E233570T1 AT 96913814 T AT96913814 T AT 96913814T AT 96913814 T AT96913814 T AT 96913814T AT E233570 T1 ATE233570 T1 AT E233570T1
Authority
AT
Austria
Prior art keywords
endothelin antagonist
antagonist
inhibitor factor
leukemia inhibitor
endothelin
Prior art date
Application number
AT96913814T
Other languages
English (en)
Inventor
Napoleone Ferrara
Kathleen King
Elizabeth A Luis
Jennie P Mather
Nicholas F Paoni
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE233570T1 publication Critical patent/ATE233570T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT96913814T 1995-04-24 1996-04-17 Verwendung des leukämie-inhibitor-faktor und endothelin antagonisten ATE233570T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42738395A 1995-04-24 1995-04-24
PCT/US1996/005498 WO1996033740A1 (en) 1995-04-24 1996-04-17 Use of leukemia inhibitory factor and endothelin antagonists

Publications (1)

Publication Number Publication Date
ATE233570T1 true ATE233570T1 (de) 2003-03-15

Family

ID=23694642

Family Applications (2)

Application Number Title Priority Date Filing Date
AT02016730T ATE313333T1 (de) 1995-04-24 1996-04-17 Verwendung eines leukämie-hemmenden faktor antagonisten
AT96913814T ATE233570T1 (de) 1995-04-24 1996-04-17 Verwendung des leukämie-inhibitor-faktor und endothelin antagonisten

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT02016730T ATE313333T1 (de) 1995-04-24 1996-04-17 Verwendung eines leukämie-hemmenden faktor antagonisten

Country Status (12)

Country Link
EP (2) EP1287832B1 (de)
JP (1) JPH11504332A (de)
AT (2) ATE313333T1 (de)
AU (1) AU702375B2 (de)
CA (1) CA2214636C (de)
DE (2) DE69626510T2 (de)
DK (2) DK0830143T3 (de)
ES (1) ES2254564T3 (de)
IL (1) IL117998A (de)
MX (1) MX9707939A (de)
WO (1) WO1996033740A1 (de)
ZA (1) ZA963274B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU753197B2 (en) 1998-07-06 2002-10-10 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Compositions and methods for in vitro fertilization
EP1549198A4 (de) * 2002-09-30 2007-03-28 Univ Duke Thymusatrophi
JP2011231014A (ja) * 2008-08-27 2011-11-17 Keiichi Fukuda 心不全の治療剤
EP2371860A1 (de) * 2010-04-05 2011-10-05 Fundació Privada Institut d'Investigació Oncològica de Vall d'Hebron Den humanen leukaemieinhibierenden Faktor (LIF) erkennender Antikörper und Verwendung von LIF-Antikörpern bei der Behandlung von Krankheiten im Zusammenhang mit ungewollter Zellproliferation
US10583191B2 (en) 2016-12-19 2020-03-10 Mosaic Biomedicals Slu Antibodies against LIF and uses thereof
CN118652335A (zh) 2016-12-19 2024-09-17 免疫医疗有限公司 抗lif抗体及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993023556A1 (en) * 1992-05-08 1993-11-25 Genentech, Inc. Antibodies to leukemia inhibitory factor
WO1995008550A1 (en) * 1993-09-24 1995-03-30 Abbott Laboratories Endothelin antagonists

Also Published As

Publication number Publication date
DE69626510D1 (de) 2003-04-10
DK0830143T3 (da) 2003-06-16
EP1287832A2 (de) 2003-03-05
ZA963274B (en) 1997-10-24
EP0830143A1 (de) 1998-03-25
AU5665896A (en) 1996-11-18
CA2214636C (en) 2009-12-22
IL117998A0 (en) 1996-08-04
JPH11504332A (ja) 1999-04-20
ATE313333T1 (de) 2006-01-15
ES2254564T3 (es) 2006-06-16
DE69626510T2 (de) 2003-12-11
DE69635630T2 (de) 2006-08-10
DK1287832T3 (da) 2006-05-01
CA2214636A1 (en) 1996-10-31
EP0830143B1 (de) 2003-03-05
MX9707939A (es) 1997-12-31
IL117998A (en) 2001-04-30
AU702375B2 (en) 1999-02-18
EP1287832A3 (de) 2003-04-16
WO1996033740A1 (en) 1996-10-31
DE69635630D1 (de) 2006-01-26
EP1287832B1 (de) 2005-12-21

Similar Documents

Publication Publication Date Title
TR199902033T2 (xx) Diyabet i�in s�lfonilura-glitazon sinerjik kombinasyonlar�.
DE69230140D1 (de) Antivirale nucleosidkombination
RO115700B1 (ro) Metodă de tratament cu interferon
ATE381935T1 (de) Verwendung von triacetyluridin zur behandlung von mitochondrialen erkrankungen
ATE185548T1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
DK0713701T3 (da) 2-Brommelatonin til behandling af søvnforstyrrelser
DE69719754D1 (de) Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung
ATE202599T1 (de) Mit isoliertem empfindlichem x-syndrom verbundene dns-sequenzen
ATE233570T1 (de) Verwendung des leukämie-inhibitor-faktor und endothelin antagonisten
TR199801988T2 (xx) Kalp yetmezli�inin endotelin antagonistleri ile tedavisi i�in y�ntem.
DK0862454T3 (da) CTLA-8 i kombination med G-CSF eller med G-CSF og IL-6 og anvendelse af CTLA-8 til behandling af infektioner
NO990450L (no) Behandling av sinnslidelser
EP0116628A4 (de) 1-acyl-3-pyridylmethylguanidine und deren verwendung als antihypertensiva.
ATE307600T1 (de) Verwendung von mycobacterium vaccae zur therapie des chronischen müdigkeitssyndrom
DE59609977D1 (de) Trapidil zur verwendung in der therapie von immunmodulatorisch beeinflussbaren krankheitsbildern
IT8519042A0 (it) Impiego di chinoloni nel trattamento di malattie cardiache.!
DK0869813T3 (da) Anvendelse af beta-interferoner til behandling af restenose
TR200000728T2 (tr) Kronik hepatit C' nin tedavisinde IFN-alfa ve amantadin kullanımı.
ES8700940A1 (es) Procedimiento de obtencion de composiciones para el trata- miento de infecciones por rinovirus
DK0900085T3 (da) Behandling af overdreven aggression med olanzapin
BR0009642A (pt) Terapia de leucemia mielocìtica crÈnica
SE9403861D0 (sv) Novel medicinal use
KR950008161U (ko) 개인용 찜질사우나
FI871737A0 (fi) Kraftanlaeggning med foerbraenning i en fluidiserad baedd.
KR900007413A (ko) 에이즈 발병방지, 치료제 및 그 치료용 조성물

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0830143

Country of ref document: EP

REN Ceased due to non-payment of the annual fee